Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Swedish firm Oasmia Pharmaceutical has completed the spin-off of its veterinary oncology business into a US subsidiary called AdvaVet.
US microbiome discovery firm Bactana Animal Health has received $400,000 in financing from Connecticut Innovations.
The first company focused on a commercial therapeutic microbiome discovery platform dedicated to animal health and nutrition has been created.
Canadian company Avivagen has sourced Can$800,000 ($626,000) from the credit facility provided by Bloom Burton Healthcare Lending Trust.
Orion Animal Health has received European approval for Clevor 30mg/ml eye drops.
A robust market for small animal innovations and vaccines has helped the German animal health industry report 3% growth in the latest financial year.
Australian firm Anatara Lifesciences has highlighted the key financial aspects of its recent agreement for Detach with Zoetis,
US animal health firm ImmuCell has seen a decrease in sales during the first quarter of 2018 as it felt the impact of manufacturing problems.
Anatara Lifesciences has signed an exclusive licensing agreement with Zoetis for the worldwide development, manufacture, distribution and marketing of Detach.
A new report indicates there is a growing world market for illegal animal medicines.
International meat and dairy traders are fighting to soften the impact of a clause in the EU's forthcoming new veterinary medicines regulation which, if unamended, could completely block imports into the EU from other countries.
Kindred Biosciences has seen its share price hit an all time high following approval of its Mirataz feline treatment in the US.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.